An observational study in which investigators will observe platelet inhibition in patients on VA ECMO acorrding to treatment with P2Y12 inhibitor.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Verify now P2Y12 platelet inhibition
Timeframe: (Time Frame: Hour 2 after VA ECMO insertion)
Verify now P2Y12 platelet inhibition
Timeframe: (Time Frame: Hour 4 after VA ECMO insertion)
Verify now P2Y12 platelet inhibition
Timeframe: (Time Frame: Hour 12 after VA ECMO insertion)
Verify now P2Y12 platelet inhibition
Timeframe: (Time Frame: Hour 22 after VA ECMO insertion)
Verify now P2Y12 platelet inhibition
Timeframe: (Time Frame: Hour 48 after VA ECMO insertion)
Verify now P2Y12 platelet inhibition
Timeframe: (Time Frame: Hour 72 after VA ECMO insertion)
Verify now P2Y12 platelet inhibition
Timeframe: (Time Frame: Hour 24 after VA ECMO removal)